Vitamin E and selenium improve mesenchymal stem cell conditioned media immunomodulatory effects. 2021

Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
Department of Medical Immunology, School of Medicine, Iran University of Medical Science, Tehran, Iran.

BACKGROUND Mesenchymal stem cells (MSCs) with immunoregulatory properties affect immune systems. Many studies showed that antioxidants such as vitamin E (Vit E) and selenium (Se) could improve stem cells survival. This study aims to investigate the effects of MSC conditioned media (CM) treated with Vit E and Se on immune cells. METHODS MSCs were isolated and cultured with Vit E and Se. Immature dendritic cells (DCs) and peripheral blood mononuclear cells (PBMCs) were cultured with MSC CM treated with Vit E and Se. The expression of HLA-DR, CD86, CD40, and CD83 on mature DC were evaluated. DC supernatant and PBMCs supernatant was collected for the study of TGF-β, IL-10, and IL-12. PBMCs evaluated for the expression of T-bet, GATA3, RORγt, and FOXP3. RESULTS MSC CM increased CD40 on myeloid DC (mDC). CD40 has been decreased in DC treated with MSC (Vit E) and MSC (Se) CM. HLA-DR expression on DCs and IL-12 level were significantly reduced in MSC (Vit E) CM. IL-10 concentration increased in DCs treated with MSC (Vit E) and MSC (Se) CM. Treatment of PBMCs with MSC CM decreased IL-10 level, FOXP3, and RORγt expression. On the other hand, the MSC (Vit E) CM and MSC (Se) CM decreased the IL-10 level and increased IL-12, T-bet, and RORγt. CONCLUSIONS According to the results, the treatment of MSC with Vit E and Se enhanced the ability of MSCs to inhibit DCs and improved immunomodulatory effects. Concerning the effect of MSC on PBMC, it seems that it increased RORγt expression through monocytes.

UI MeSH Term Description Entries

Related Publications

Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
March 2024, Current drug discovery technologies,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
November 2021, Stem cell research & therapy,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
November 2018, Journal of cellular physiology,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
March 2022, Scientific reports,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
January 2019, Case reports in dermatological medicine,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
January 2016, Journal of stem cells,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
January 2020, Frontiers in immunology,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
July 2020, Journal of cellular physiology,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
January 2019, Frontiers in pharmacology,
Fereshteh Ghasemi, and Majid Khoshmirsafa, and Elahe Safari, and Marzieh Asgari, and Mehdi Alemrajabi, and Shahrzad Nojehdehi, and Samane Khorrami
June 2012, Stem cells and development,
Copied contents to your clipboard!